Tag: Psoriasis

Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream

Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% Cream

| November 1, 2018

 J Clin Aesthet Dermatol. 2018;11(11):15–19 by Neal D. Bhatia, MD; David M. Pariser, MD; Leon Kircik, MD; Tina Lin, PharmD; Susan Harris, MS; Lindsey Mathew; and Radhakrishnan Pillai, PhD Dr. Bhatia is with Therapeutics Clinical Research in San Diego, California. Dr. Pariser is with Virginia Clinical Research, Inc. in Norfolk, Vriginia. Dr. Kircik is with […]

Continue Reading

Updates in  Psoriasis Management: Based on Selected Presentations from Maui Derm 2018

Updates in Psoriasis Management: Based on Selected Presentations from Maui Derm 2018

| October 1, 2018

J Clin Aesthet Dermatol 2018;11(10):S5–S23 A Message from the Guest Editor and MauiDerm Program Director   Dear Colleagues:  Each year, Maui Derm strives to bring to the podium the most up-to-date and cutting edge scientific and clinical developments in the field of dermatology. Maui Derm 2018 was no exception—our outstanding faculty delivered a mind-numbing amount of […]

Continue Reading

October 2018 Supplement Digital Edition

October 2018 Supplement Digital Edition

| October 1, 2018

Continue Reading

A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis

A Case-control Study to Evaluate the Prevalence of Nonalcoholic Fatty Liver Disease Among Patients with Moderate-to-severe Psoriasis

| June 1, 2018

by Olabola Awosika MD, MS; Misty G. Eleryan MD; Monica Rengifo-Pardo MD; Lindsay Doherty MS; Lisa W. Martin, MD; and Alison Ehrlich MD, MHS Drs. Awosika, Rengifo-Pardo, and Ehrlich are with the Department of Dermatology, The George Washington Medical Faculty Associates in Washington, DC. Dr. Martin is with the Department of Cardiology, The George Washington Medical […]

Continue Reading

MauiDerm for Dermatologists: Selected Abstracts from the 2018 Meeting

MauiDerm for Dermatologists: Selected Abstracts from the 2018 Meeting

| May 1, 2018

Click to view the e-Edition of this supplement A Message from the Guest Editor and MauiDerm Program Director Dear Colleagues: The 2018 edition of the MauiDerm for Dermatologists meeting had a wide variety of clinical and scientific data presented not only at the podium, but in its poster sessions as well. A wide range of […]

Continue Reading

An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis

An Open-label, Observational Study Evaluating Desoximetasone Topical Spray 0.25% in Patients with Scalp Psoriasis

| May 1, 2018

by Jerry Bagel, MD, MS, and Elise Nelson, LPN, CCRC Both authors are with the Psoriasis Treatment Center of Central New Jersey in East Windsor, New Jersey. J Clin Aesthet Dermatol. 2018;11(5):27–29 Funding: This study was sponsored by Taro Pharmaceuticals U.S.A., Inc. Disclosures: The authors have no conflicts of interest relevant to the content of […]

Continue Reading

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis

Efficacy, Safety, and Potency of Betamethasone Dipropionate Spray 0.05%: A Treatment for Adults with Mild-to-moderate Plaque Psoriasis

| April 1, 2018

by Srinivas Sidgiddi, MD, Refika I. Pakunlu, PhD, and Kent Allenby, MD Drs. Sidgiddi, Pakunlu, and Allenby are with Promius Pharma, a subsidiary of Dr. Reddy’s Laboratories, in Princeton, New Jersey. Funding: This study was funded and sponsored by the Dr. Reddy’s Laboratories group of companies in Princeton, New Jersy, USA Disclosures: Drs. Sidgiddi, Pakunlu, […]

Continue Reading